logo
Poinguinim boar attack victim compensated

Poinguinim boar attack victim compensated

Time of India19 hours ago

Canacona:
The forest department paid a compensation of Rs 85,000 to Jayanti Velip, who developed deformities from a wild boar attack in Jan.
The compensation papers were prepared by the assistant conservator of forests (South) Harsh Phadte and range forest officer, Canacona, Anant Velip, under the supervision of the deputy conservator of forests (South), Satish Kumar Reddy.
Velip was working in a paddy field at Velwada, Poinguinim when a wild boar attacked her from behind. She fought with the boar and suffered injuries, resulting in 82% disability to her thumb and ear, she told
TOI
. After the attack, she was hospitalised for over two months and is now unable to use her right thumb or hear properly with her one ear.
Get the latest lifestyle updates on Times of India, along with
Eid wishes
,
messages
, and
quotes
!

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How animal bite deaths hit MP villagers even after rabies vaccination
How animal bite deaths hit MP villagers even after rabies vaccination

India Today

time29 minutes ago

  • India Today

How animal bite deaths hit MP villagers even after rabies vaccination

A spate of deaths has hit a group of mostly tribal people who had assembled for a wedding at Limbai village in Madhya Pradesh's Barwani district, spreading panic. Six people have died since early May—the last one on June 2—after being bitten by an animal suspected to be a rabid morning on May 5, an animal bit 17 people sleeping outside their homes in Limbai, located some 45 km from Barwani town. The victims, some of whom had come from other villages for a wedding, described the animal as resembling a search was launched but the animal was never traced, until on June 4 when forest department staff found the remains of an animal, with its legs tied, in a dry well near the village.'We suspect the remains are that of a jackal. The animal was perhaps caught, killed and thrown into the well. We have sent the remains for a lab test,' said Ashish Bansod, divisional forest officer, Barwani. Three people died on May 23, one each on May 27 and June 1 and another person on June 2. All of them had been administered anti-rabies vaccines immediately after being bit. Three heads of cattle also died after being bitten by the families of the deceased have been paid Rs 8 lakh each as compensation, informed could have caused the deaths even after vaccines were administered? The district administration has sent samples of the vaccines for tests. Samples and swabs drawn from the deceased have also been sent for tests to ascertain if the fatalities were indeed caused by rabies.'If not stored properly or if the cold chain is broken, the efficacy of drugs may reduce. At times, if the schedule of injections is not followed, efficacy goes down as well,' said Dr Avinash Dube, a medical remaining 11 people who suffered bites are under observation at medical facilities, including the MY Hospital at divisional headquarters Indore. 'There is panic among the affected since the deaths happened even after taking the vaccine shots,' said a family to India Today Magazine

81,000 Vials, Rs 24 Crore In 3 Months: Weight Loss Drug Mounjaro Sales Triple As Patients Shift To Higher Dose
81,000 Vials, Rs 24 Crore In 3 Months: Weight Loss Drug Mounjaro Sales Triple As Patients Shift To Higher Dose

News18

time33 minutes ago

  • News18

81,000 Vials, Rs 24 Crore In 3 Months: Weight Loss Drug Mounjaro Sales Triple As Patients Shift To Higher Dose

With three months since its launch in India, according to latest Pharmatrac data, Mounjaro clocked Rs 12.6 crore in sales in May 2025—a threefold increase from March In a sign of rising adoption, sales of Mounjaro—the breakthrough weight loss and type 2 diabetes drug—have nearly tripled in the last two months, data shows. American drugmaker Eli Lilly launched Mounjaro in India on March 20, triggering immediate frenzy, especially among those looking to achieve weight loss and glucose control. Doctors told News18 they were flooded with requests from patients eager to start Mounjaro or learn more about its benefits. With three months since its launch in India, according to latest Pharmatrac data, Mounjaro clocked Rs 12.6 crore in sales in May 2025—a threefold increase from March. The higher dosage form of five milligram, in particular, more than doubled in value and quantity sales between April and May, indicating a strong trend of patient progression to the next stage of treatment. As per the medical protocol, patients start with lower dosage of 2.5 milligram weekly dose and upgrade to 5 milligram after four weeks. 'This clinical shift is clearly reflected in market numbers. Five mg pack sales jumped from Rs 3.08 crore in April to Rs 7.53 crore in May, while unit sales rose from over 9,300 to over 22,900," Sheetal Sapale, vice-president (commercial), Pharmatrac, told News18. 'Looking at these trends and the acceptance of this therapy—by physicians as well as patients—along with the affordable pricing of Rs 18,000 to Rs 22,000 per month dosage indicates a definite pick up in consumption." The total market for Mounjaro has reached Rs 23.94 crore over the past three months, selling more than 81,000 vials of the drug—signalling growing adoption in diabetes care protocols. According to Dr Anoop Misra, chairman, Fortis C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, clinical use of Mounjaro in India closely reflects the trends observed in the data. 'A substantial number of patients are being initiated at 2.5 mg, with a timely escalation to 5 mg in line with recommended protocols. This pattern suggests good tolerability and early clinical efficacy in glycemic control and weight reduction." Misra told News18: 'With growing familiarity and broader access, increased use of higher doses (7.5 mg and above) is likely, especially in patients requiring enhanced metabolic outcomes." The injectable drug is approved by India's apex drug regulatory body, Central Drugs Standard Control Organisation (CDSCO). Mounjaro is a once-weekly injection priced at Rs 4,375 for a 5 mg vial and Rs 3,500 for a 2.5 mg vial, making the monthly expenditure around Rs 14,000-Rs 17,500. The drug is claimed to be 80 per cent cheaper than in the United States. Entry-Level Dosage Sales Plateau Mounjaro, the brand name for Tirzepatide, a once-weekly injectable, is a first-in-class medication that combines the effects of two naturally occurring hormones: GIP (Gastric Inhibitory Polypeptide) and GLP-1 (Glucagon-Like Peptide-1). Data shows that the 2.5mg dose of Mounjaro—generally prescribed as the starting regimen for type 2 diabetes patients or those looking to shed weight—has shown signs of 'plateauing growth". This trend confirms a gradual shift to higher doses. The sales value for the 2.5 mg injection rose marginally from Rs 4.80 crore in April to Rs 5.08 crore in May, after a steeper increase from Rs 1.42 crore in March. The data shows that the unit sales also reflect this trend, increasing from 5,400 in March to 18,270 in April, but only marginally to 19,350 in May. While the 2.5 mg variant remains essential for entry-level patient initiation, its month-on-month growth may continue to taper off as the patient base matures and advances to the next phase of dosing.

PG medical student arrested for hoax bomb threat to skip seminar in Mangaluru
PG medical student arrested for hoax bomb threat to skip seminar in Mangaluru

Time of India

timean hour ago

  • Time of India

PG medical student arrested for hoax bomb threat to skip seminar in Mangaluru

MANGALURU: The Mangaluru City police arrested a postgraduate medical student for making a hoax bomb threat to a private hospital under Ullal Police Station limits. The accused has been identified as Dr Chalasani Monica Choudary. City Police Commissioner Sudheer Kumar Reddy CH stated that the preliminary investigation revealed the accused was scheduled to present a seminar on the day of the incident. In an attempt to avoid the presentation, she allegedly made a hoax call to the hospital. The incident occurred on June 4 at around 8.45 am when the hospital received a threatening call claiming a bomb was planted on the premises and instructing that the hospital be evacuated by 11 am. The hospital reportedly received at least five such calls. Following the alert, around 25 to 30 police personnel, including members of the Bomb Detection and Disposal Squad (BDDS) and dog squad, rushed to the spot and thoroughly searched the hospital, its parking facility, and surrounding areas. However, no explosive device was found. The hoax created panic among doctors, staff, and patients. Interestingly, the PG student herself filed a complaint about the threat, leading to a case being registered under Sections 352(2), 352(4) of the Bharatiya Nyaya Sanhita (BNS) at the Ullal police station. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like This Device Made My Power Bill Drop Overnight elecTrick - Save upto 80% on Power Bill Pre-Order Undo A special team was formed to trace the caller. Based on technical data analysis, police found that the complainant was in fact the caller. She was arrested on Saturday. Her statement was recorded, and her mobile phone was seized for further investigation, which is in progress. Get the latest lifestyle updates on Times of India, along with Eid wishes , messages , and quotes !

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store